Terms: = Cervical cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Treatment
216 results:
1. High p16ink4a Expression, Keratinizing Features, and Surgical Margin-Free Status are Associated with Improved Survival in Patients with Oral Squamous Cell Carcinomas.
Anwar SL; Dwianingsih EK; Lestari SP; Sugandhi W; Cahyono R; Pradana GD
Asian Pac J Cancer Prev; 2024 Mar; 25(3):857-865. PubMed ID: 38546068
[TBL] [Abstract] [Full Text] [Related]
2. Should we use risk selection tests for HPV 16 and/or 18 positive cases: Comparison of p16/Ki67 and cytology.
Mazurec K; Trzeszcz M; Mazurec M; Streb J; Halon A; Jach R
J Med Virol; 2024 Mar; 96(3):e29500. PubMed ID: 38440951
[TBL] [Abstract] [Full Text] [Related]
3. Predictive and prognostic biomarkers in female genital tract tumours: an update highlighting their clinical relevance and practical issues.
Wong RW; Cheung ANY
Pathology; 2024 Mar; 56(2):214-227. PubMed ID: 38212229
[TBL] [Abstract] [Full Text] [Related]
4. Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary.
Barquín García A; Palacios-Zambrano S; Lozano Alarcón F; Paumard-Hernández B; Quiralte Pulido M; Navarro P; Rodríguez L; Salas Villar I; García-Donas J
J Natl Compr Canc Netw; 2023 Dec; 22(1D):e237079. PubMed ID: 38150820
[TBL] [Abstract] [Full Text] [Related]
5. The use of colposcopy for triage in HPV-positive women aged 65 years and older.
Kuenkel E; Jaeger A; Bohlmann I; Bergauer F; Kuehler-Obbarius C; Prieske K; Maass-Poppenhusen K; Schmalfeldt B; Woelber L
Arch Gynecol Obstet; 2024 Apr; 309(4):1561-1567. PubMed ID: 38081959
[TBL] [Abstract] [Full Text] [Related]
6. The effects of the LaSota strain of oncolytic Newcastle disease virus vaccine on cervical intraepithelial neoplasia Patients-Clinical cohort study.
Sharifi N; Bouzari M; Keyvani H; Mehdi Ranjbar M
Int Immunopharmacol; 2024 Jan; 126():111296. PubMed ID: 38041958
[TBL] [Abstract] [Full Text] [Related]
7. Whole genome sequencing in high-grade cervical intraepithelial neoplasia patients from different ethnic groups in China.
Wang J; Li M; Zhao L; Zhou B; Chen H; Duan F; Wang G
Medicine (Baltimore); 2023 Nov; 102(45):e35953. PubMed ID: 37960754
[TBL] [Abstract] [Full Text] [Related]
8. Cutaneous metastasis from cervical cancer to the scalp and trunk: a case report and review of the literature.
Dai Y; Zhang Y; Ke X; Liu Y; Zang C
J Med Case Rep; 2023 Oct; 17(1):435. PubMed ID: 37853494
[TBL] [Abstract] [Full Text] [Related]
9. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
[TBL] [Abstract] [Full Text] [Related]
10. The relationship of immunohistochemical SOX-2 staining with histopathological diagnosis in patients with abnormal colposcopic findings.
Atıgan A; Kılıç D; Karakaya YA; Gök S; Güler ÖT
Histochem Cell Biol; 2023 Dec; 160(6):555-561. PubMed ID: 37558931
[TBL] [Abstract] [Full Text] [Related]
11. Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
Desravines N; Hsu CH; Mohnot S; Sahasrabuddhe V; House M; Sauter E; O'Connor S; Bauman JE; Chow HS; Rahangdale L
Int J Gynaecol Obstet; 2023 Dec; 163(3):862-867. PubMed ID: 37431689
[TBL] [Abstract] [Full Text] [Related]
12. Unilateral ovarian recurrence 5 years after hysterectomy for microinvasive squamous cervical cancer stage IA1: a rare case report.
Tong L; Wu L
BMC Womens Health; 2023 Jul; 23(1):350. PubMed ID: 37393247
[TBL] [Abstract] [Full Text] [Related]
13. Association of MicroRNA-10b Expression and p16 with Pathological Features in Various Stages of cervical Precancerous Lesions.
Deng Y; Jiang H; Wu D
Cell Mol Biol (Noisy-le-grand); 2023 Jan; 69(1):109-113. PubMed ID: 37213147
[TBL] [Abstract] [Full Text] [Related]
14. High-grade squamous intraepithelial lesion cervicovaginal paps with negative high-risk HPV testing, a prospective study with histological follow-up.
Agoff SN; Brockmeyer AD; Barrie AM; Larson J
Diagn Cytopathol; 2023 Aug; 51(8):475-479. PubMed ID: 37086174
[TBL] [Abstract] [Full Text] [Related]
15. Patient, disease, and survival outcomes for stage IB to stage IV cervical cancer-A population study.
Wang C; Lester B; Huang L; Sun S; Ko JJ
Womens Health (Lond); 2023; 19():17455057231164551. PubMed ID: 37052298
[TBL] [Abstract] [Full Text] [Related]
16. High-grade and low-grade HPV-induced urethral lesions treated by CO
Aynaud O; Huynh B; Bergeron C
Sex Transm Infect; 2023 Jun; 99(4):279-282. PubMed ID: 36990695
[TBL] [Abstract] [Full Text] [Related]
17. Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)-Study protocol.
Okunade KS; Badmos KB; Okoro AC; Ademuyiwa IY; Oshodi YA; Adejimi AA; Awolola NA; Ozonu O; Adelabu H; Olorunfemi G; Akanmu AS; Banjo AA; Anorlu RI; Berek JS
PLoS One; 2023; 18(1):e0278077. PubMed ID: 36701329
[TBL] [Abstract] [Full Text] [Related]
18. Condyloma acuminatum mimicking cervical cancer in a pregnant woman and treatment with cryotherapy: A case report.
Chang KC; Chen YC; Ding DC
Medicine (Baltimore); 2022 Dec; 101(49):e32273. PubMed ID: 36626521
[TBL] [Abstract] [Full Text] [Related]
19. HPV-positive cervical squamous cell carcinoma metastasis to the breast, mimicking primary tumor.
de Oliveira-Junior I; Barbin FF; Watanabe AHU; Dos Reis R; da Costa Vieira RA
Breast Dis; 2022; 41(1):407-411. PubMed ID: 36502298
[TBL] [Abstract] [Full Text] [Related]
20. Utility of high-risk HPV RNA chromogenic in situ hybridization in cytology smears and liquid-based preparations from metastatic head and neck squamous cell carcinoma.
Velez Torres JM; Alkathery T; Tjendra Y; Zuo Y; Kerr DA; Gomez-Fernandez C
Cancer Cytopathol; 2023 Mar; 131(3):165-170. PubMed ID: 36350307
[TBL] [Abstract] [Full Text] [Related]
[Next]
